Woodline Partners LP Kymera Therapeutics, Inc. Transaction History

Woodline Partners LP

$11 Billion
Q3 2024

A detailed history of Woodline Partners LP transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 525,094 shares of KYMR stock, worth $23.3 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

525,094

Previous 517,797 1.41%

Holding current value

$23.3 Million

Previous $15.5 Million 60.79%

% of portfolio

0.23%

Previous 0.16%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$30.16 - $52.4 $220,077 - $382,362	7,297 Added 1.41%	525,094 $24.9 Million
Q2 2024 Aug 14, 2024	BUY	$29.85 - $39.42 $503,479 - $664,897	16,867 Added 3.37%	517,797 $15.5 Million
Q1 2024 May 15, 2024	BUY	$22.9 - $43.57 $9.16 Million - $17.4 Million	400,179 Added 397.2%	500,930 $20.1 Million
Q4 2023 Feb 14, 2024	SELL	$10.97 - $26.84 $26,744 - $65,435	-2,438 Reduced 2.36%	100,751 $2.57 Million
Q3 2023 Nov 14, 2023	SELL	$13.9 - $23.88 $77,728 - $133,536	-5,592 Reduced 5.14%	103,189 $1.43 Million
Q2 2023 Aug 14, 2023	BUY	$22.4 - $34.92 $196,470 - $306,283	8,771 Added 8.77%	108,781 $2.5 Million
Q1 2023 May 15, 2023	BUY	$24.84 - $38.75 $248 - $387	10 Added 0.01%	100,010 $2.96 Million
Q2 2022 Aug 15, 2022	BUY	$14.13 - $42.55 $1.41 Million - $4.26 Million	100,000 New	100,000 $1.97 Million
Q4 2021 Feb 14, 2022	SELL	$49.91 - $65.56 $6.45 Million - $8.48 Million	-129,331 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$47.8 - $66.66 $4.38 Million - $6.1 Million	91,572 Added 242.52%	129,331 $7.6 Million
Q2 2021 Aug 16, 2021	BUY	$31.08 - $51.95 $1.17 Million - $1.96 Million	37,759 New	37,759 $1.83 Million
Q1 2021 May 17, 2021	SELL	$35.64 - $85.46 $6.05 Million - $14.5 Million	-169,687 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$28.07 - $87.83 $97,402 - $304,770	3,470 Added 2.09%	169,687 $10.5 Million
Q3 2020 Nov 16, 2020	BUY	$26.1 - $33.28 $4.34 Million - $5.53 Million	166,217 New	166,217 $5.37 Million

Others Institutions Holding KYMR

# of Institutions

183

Shares Held

64.3M

Call Options Held

50.6K

Put Options Held

81.7K

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.43B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Account

Woodline Partners LP Kymera Therapeutics, Inc. Transaction History